Keivan Javanshiri- MD PhD
- PhD at Lund University
Keivan Javanshiri
- MD PhD
- PhD at Lund University
About
17
Publications
1,664
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
128
Citations
Introduction
Keivan Javanshiri has a PhD from research conducted at the Department of Pathology in Lund, Lund University, Sweden where he focused on:
1 - Cardiovascular disease and risk factors in major neurocognitive disorders.
2 - Cardiac alpha-synuclein and its role in the cause of death in alpha-synucleinopathies.
Keivan is also a MD at Skane University Hostpital in Lund, currently doing his residency in Oncology.
Current institution
Additional affiliations
August 2018 - present
Position
- PhD Student
Description
- Working within the neuropathology-group in Lund with a project about cardiovascular and cerebrovascular disease in dementia.
January 2017 - June 2018
Position
- Lecturer
Description
- Lectured and educated MD students in autopsy and anatomy as an eminent senior student. Responsible for the education and management of other student tutors.
Education
August 2018 - August 2022
January 2013 - January 2019
Publications
Publications (17)
Increasing evidence suggests that Lewy body disease (LBD) is associated with clinically important cardiac complications, including sick sinus syndrome, atrial fibrillation and sudden cardiac death. The high prevalence of sick sinus syndrome and atrial fibrillation in LBD suggests the presence of disease-related atrial conduction disorders. To explo...
As the population of the world increases, there will be a larger number of people with major neurocognitive disorder and an emerging need for prompt diagnosis and treatment. A digital cognitive test could lead to that more people can be tested without burdening healthcare. To explore elderly's experiences of using a digital cognitive test a cogniti...
Background
There is a need for the development of accurate, accessible and efficient screening instruments, focused on early-stage detection of neurocognitive disorders. The Geras Solutions cognitive test (GSCT) has showed potential as a digital screening tool for cognitive impairment but normative data are needed.Objective
The aim of this study wa...
The purpose of this study was to investigate the cause of death in subjects with α-synucleinopathies (ASs) and the confirmed presence of cardiac α-synuclein (α-syn), compared to non-AS disorders in a neuropathologically confirmed cohort. In total, 78 neuropathologically confirmed AS cases positive for cardiac α-syn were included in the study. Indiv...
The prevalence and association of cardiovascular disease on autopsy, hypertension and type 2 diabetes mellitus in Alzheimer's disease, Lewy body disease, mixed dementia, and vascular dementia.
The prevalence of cardiac alpha-synuclein and its role in the cause of death in alpha-synucleinopathies.
Background
There are few studies on the locus coeruleus (LC) in frontotemporal lobar degeneration (FTLD) and the potential differences in the LC related to the underlying proteinopathy.
Objective
The aim of this study was to investigate the LC in FTLD subgroups.
Methods
Neuropathological cases diagnosed with FTLD were included. The subgroups cons...
Background
Alpha-synucleinopathies (AS) are characterized by pathologic aggregations of alpha-synuclein (α-syn) in the central nervous system, and comprise dementia with Lewy bodies, Parkinson’s disease, and multiple system atrophy. Previous studies on AS have reported findings of α-syn pathology in the peripheral nervous system of multiple organs,...
Background
Research concerning the potential roles of cardiovascular disease (CaVD) and diabetes mellitus (DM) as risk factors for Lewy body disease (LBD) is limited. These disorders are, however, established risk factors for vascular dementia (VaD) and have been proposed as risk factors for Alzheimer’s disease (AD).
Objective
The aim of this stud...
We examined and compared the prevalence of atherosclerosis in the coronary arteries and the aorta, heart hypertrophy, heart infarction, nephrosclerosis, hypertension and diabetes in neuropathologically confirmed cases of Alzheimer´s disease, vascular dementia and mixed dementia respectively.
The macro- and microscopical findings were obtained thro...
We examined and compared the prevalence of atherosclerosis in the coronary arteries and the aorta, heart hypertrophy, heart infarction, nephrosclerosis, hypertension and diabetes in neuropathologically confirmed cases of Alzheimer´s disease, vascular dementia and mixed dementia respectively.
The macro- and microscopical findings were obtained thro...
We examined and compared the prevalence of atherosclerosis, heart hypertrophy, heart infarction, nephrosclerosis, hypertension and diabetes in neuropathologically confirmed cases of Alzheimer´s disease, vascular dementia and mixed dementia respectively.
The macro- and microscopical findings were obtained through autopsy reports and neuropathologic...
We examined and compared the prevalence of atherosclerosis, heart hypertrophy, heart infarction, nephrosclerosis, hypertension and diabetes in neuropathologically confirmed cases of Alzheimer´s disease, vascular dementia and mixed dementia respectively.
The macro- and microscopical findings were obtained through autopsy reports and neuropathologic...
Background
Alzheimer’s disease (AD) is the most prevalent cause of dementia with vascular dementia (VaD) being second alongside with mixed AD and VaD, according to some. For some time, it has been proposed that cardiovascular disease (CaVD), hypertension, and diabetes mellitus (DM), which are known risk factors for VaD, also are associated with and...
